These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21054342)

  • 21. Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids.
    Marill J; Capron CC; Idres N; Chabot GG
    Biochem Pharmacol; 2002 Mar; 63(5):933-43. PubMed ID: 11911845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
    Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
    Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silybin is metabolized by cytochrome P450 2C8 in vitro.
    Jancová P; Anzenbacherová E; Papousková B; Lemr K; Luzná P; Veinlichová A; Anzenbacher P; Simánek V
    Drug Metab Dispos; 2007 Nov; 35(11):2035-9. PubMed ID: 17670841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes.
    Nakashima A; Kawashita H; Masuda N; Saxer C; Niina M; Nagae Y; Iwasaki K
    Xenobiotica; 2005 Jun; 35(6):589-602. PubMed ID: 16192110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes.
    Lee HS; Ji HY; Park EJ; Kim SY
    Xenobiotica; 2007 Aug; 37(8):803-17. PubMed ID: 17701830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.
    Wang JS; DeVane CL
    Drug Metab Dispos; 2003 Jun; 31(6):742-7. PubMed ID: 12756206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes.
    Kim KA; Park JY; Lee JS; Lim S
    Arch Pharm Res; 2003 Aug; 26(8):631-7. PubMed ID: 12967198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.
    Yamazaki H; Shibata A; Suzuki M; Nakajima M; Shimada N; Guengerich FP; Yokoi T
    Drug Metab Dispos; 1999 Nov; 27(11):1260-6. PubMed ID: 10534310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Kinetic Characterization of Axitinib Metabolism.
    Zientek MA; Goosen TC; Tseng E; Lin J; Bauman JN; Walker GS; Kang P; Jiang Y; Freiwald S; Neul D; Smith BJ
    Drug Metab Dispos; 2016 Jan; 44(1):102-14. PubMed ID: 26512042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors.
    Jaakkola T; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):44-51. PubMed ID: 16867170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
    Baldwin SJ; Clarke SE; Chenery RJ
    Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
    Rifkind AB; Lee C; Chang TK; Waxman DJ
    Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.
    Rowbotham SE; Illingworth NA; Daly AK; Veal GJ; Boddy AV
    Drug Metab Dispos; 2010 Jul; 38(7):1211-7. PubMed ID: 20308471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.
    Li XQ; Björkman A; Andersson TB; Ridderström M; Masimirembwa CM
    J Pharmacol Exp Ther; 2002 Feb; 300(2):399-407. PubMed ID: 11805197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver.
    Yasuda K; Ikushiro S; Kamakura M; Munetsuna E; Ohta M; Sakaki T
    Drug Metab Dispos; 2011 Sep; 39(9):1538-45. PubMed ID: 21622626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.